Evidence map›Paper›PMID 41413600›Full record

ArticleJournal of cheminformatics2025

RetroScore: graph edit distance-guided retrosynthesis for accessibility scoring with route metrics.

Sinuo Gao, Xiaofei Zhou, Lu Liang, Jianping Lin

Abstract read
In one paragraph

Article in Journal of cheminformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sinuo GaoState Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, 300350, China.
Xiaofei ZhouTianjin BioAI-Global Technology Co., Ltd, Tianjin, 300140, China.
Lu LiangTianjin BioAI-Global Technology Co., Ltd, Tianjin, 300140, China. lianglu@bioai-global.com.
Jianping LinState Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, 300350, China. jianpinglin@nankai.edu.cn.

Funding

National Key Research and Development Program of China No.2022YFD1802102
6 · The paper itself

Abstract

Molecular generation is a critical method in drug design, but its practical application is often limited by the difficulty of synthesizing the generated molecules. To address this challenge, we present RetroScore, a synthetic accessibility evaluation framework guided by multistep retrosynthesis. Our methodology integrates the semi-template model Graph2Edits with the multistep retrosynthesis planning algorithm Retro*, forming the Graph2Edits-Retro*d system. By incorporating the green chemistry metric of graph edit distance into the reaction cost function and a multistage screening protocol, this system identifies optimal routes while balancing reliability, synthetic efficiency, and economic feasibility. Benchmark evaluations demonstrate a 97.37% planning success rate with balanced optimization across route length, confidence score, and graph edit distance. In the molecular generation task, the RetroScore outperforms six of the seven synthetic accessibility metrics, yielding molecules with enhanced synthetic accessibility profiles across heterogeneous evaluation frameworks. To facilitate practical implementation, we developed an open-access web platform for automated retrosynthesis route prediction and RetroScore calculation, providing researchers with rapid synthetic accessibility assessments. The RetroScore web server is publicly accessible at http://aidd.bioai-global.com/RetroScore/ , and the source code is available at https://github.com/Snowgao320/RetroScore .

Indexed as

Molecular generationRetrosynthesisSynthesis planningSynthetic accessibility

Identifiers

PMID41413600
PMCPMC12828956

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.